No abstract available
MeSH terms
-
Adult
-
Anaplastic Lymphoma Kinase
-
Bone Neoplasms / drug therapy
-
Bone Neoplasms / secondary*
-
Brain Neoplasms / drug therapy
-
Brain Neoplasms / secondary*
-
Carbazoles / therapeutic use
-
Carcinoma, Non-Small-Cell Lung / drug therapy*
-
Carcinoma, Non-Small-Cell Lung / enzymology
-
Carcinoma, Non-Small-Cell Lung / genetics*
-
Carcinoma, Non-Small-Cell Lung / pathology
-
Clinical Trials, Phase III as Topic
-
Crizotinib
-
Drug Resistance, Multiple
-
Female
-
Gene Fusion
-
Humans
-
Lung Neoplasms / drug therapy*
-
Lung Neoplasms / enzymology
-
Lung Neoplasms / genetics
-
Lung Neoplasms / pathology
-
Mutation*
-
Piperidines / therapeutic use
-
Protein Kinase Inhibitors / therapeutic use
-
Pyrazoles / therapeutic use*
-
Pyridines / therapeutic use*
-
Randomized Controlled Trials as Topic
-
Receptor Protein-Tyrosine Kinases / genetics*
Substances
-
Carbazoles
-
Piperidines
-
Protein Kinase Inhibitors
-
Pyrazoles
-
Pyridines
-
Crizotinib
-
ALK protein, human
-
Anaplastic Lymphoma Kinase
-
Receptor Protein-Tyrosine Kinases
-
alectinib